PhRMA's SVP says newspaper overlooks benefit of DTC

Share this article:
PhRMA SVP Ken Johnson, responding to a Christian Science Monitor piece critical of drug DTC advertising, said the newspaper "unfortunately overlooks the educational benefits of direct-to-consumer advertising of prescription medicines."

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions